Cargando…
Proof of Concept to Clinical Confirmation: Evolving Clinical Trial Designs for Targeted Agents
No single therapy benefits the majority of patients in the practice of oncology as responses differ even among patients with similar tumor types. The variety of response to therapy witnessed while treating our patients supports the concept of personalized medicine using patients' genomic and bi...
Autores principales: | Finn, Laura, Tan, Winston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371752/ https://www.ncbi.nlm.nih.gov/pubmed/22701804 http://dx.doi.org/10.5402/2012/478607 |
Ejemplares similares
-
Designing and conducting proof-of-concept chronic pain analgesic clinical trials
por: Campbell, Claudia M., et al.
Publicado: (2019) -
Turoctocog alfa (NovoEight®) – from design to clinical proof of concept
por: Ezban, Mirella, et al.
Publicado: (2014) -
Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control
por: Evans, Alicia, et al.
Publicado: (2011) -
Myocardial Viability: From Proof of Concept to Clinical Practice
por: Bhat, Aditya, et al.
Publicado: (2016) -
Immuno-PET: Design options and clinical proof-of-concept
por: Lugat, Alexandre, et al.
Publicado: (2022)